Pasithea Therapeutics’ Acquisition of AlloMek Therapeutics | McDermott

McDermott Will & Schulte, a global law firm

COVERAGE

Pasithea Therapeutics’ Acquisition of AlloMek Therapeutics

October 26, 2022

Read time: 2 min

McDermott Will & Emery represented Pasithea Therapeutics Corp. in the transaction. The team was led by Robert Cohen and Eric Klee and included James Behrens, Mark Bilut, Cristell Fortune, Anisa Mohanty, Nick Paul, David Saunders, Michael Siekman, Jeronimo Soares de Sousa, Todd Solomon, Michelle Strowhiro, Kate Williams and Daniel Zucker.

Robert H. Cohen

Partner

Miami

Mark A. Bilut

Partner

Chicago

Nick Paul

Partner

Chicago

David P. Saunders

Partner

Chicago

Todd A. Solomon

Partner

Chicago

You may also like